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E-mail address: mhusain@lrri.org (M. Husain).Histone deacetylase 6 (HDAC6) is a multi-substrate cytoplasmic enzyme that regulates many impor-
tant biological processes. Recently, some reports have implicated HDAC6 in viral infection. However,
nothing is known about its regulation in virus-infected cells. The data presented here for the ﬁrst
time demonstrate the caspase-3-mediated cleavage of HDAC6 in inﬂuenza A virus (IAV)-infected
cells. HDAC6 polypeptide contains the caspase-3 cleavage motif DMAD-S at the C-terminus, and is
a caspase-3 substrate. The cleavage removes most of the C-terminal ubiquitin-binding zinc ﬁnger
domain from HDAC6, which could be signiﬁcant for HDAC6’s role in IAV-induced apoptosis in
infected cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Histone deacetylases (HDACs), which have been implicated in
mediating diverse cellular processes, are divided into three classes.
Class I includes HDAC1, 2, 3, and 8, and class II contains HDAC4, 5, 6,
7, 9, and 10. HDAC11 is in a unique class, which shares similarities
with classes I and II. Class III comprises the Sir2-like deacetylases
SIRT1 to 7. HDAC6 is unique among class II deacetylases because
it contains two catalytic domains and a zinc ﬁnger motif. HDAC6
is a cytoplasmically localized protein that potentially regulates sev-
eral cellular functions. In vivo, the enzymatic activity of HDAC6 is
exerted on a-tubulin, heat-shock protein 90 (hsp90), and cortactin;
whereas, in vitro, HDAC6 also deacetylates histones. In addition to
the identiﬁcation of its enzymatic substrates, several HDAC6-inter-
acting proteins also have been identiﬁed (reviewed in [1]).
Besides its role in a wide range of cellular activities, involve-
ment of HDAC6 in viral infections also has been reported lately
[1]. HDAC6 regulates the HIV-1 infection by altering the acetyla-
tion status of cortical a-tubulin [2]. In human T-cell leukemia
virus-infected cells inhibition of HDAC6 activity leads to thechemical Societies. Published by E
; HDAC, histone deacetylase;
s; INF, infected; M1, matrix
E, normal human bronchial
cid repeats; UNI, uninfected;
Drive, SE, Albuquerque, NMenhanced viral gene expression [3]. Because HDAC6 also is
involved in actin remodeling underneath the plasma membrane
[4], which is the site of inﬂuenza A virus (IAV) assembly, we are
investigating the role and regulation of HDAC6 during IAV
infection. IAV is the prototype of family Orthomyxoviridae and
possesses a segmented negative-sense RNA genome. Inﬂuenza
viruses are among the most common and signiﬁcant causes of
human respiratory infections because of their ability to cause high
morbidity and mortality. IAV infects airway epithelium in the
upper and lower respiratory tracts. Seasonal IAV strains cause
tracheobronchitis and pharyngitis but rarely cause fatal alveolar
pneumonia. However, pneumonia is the most common lesion in
patients infected with the highly pathogenic avian IAV H5N1 strain
[5]. IAV infection results in the induction of apoptosis both in cell
culture and in vivo [6–8]. In a recent study, apoptosis was observed
among the alveolar epithelial cells of two patients who died of
H5N1 infection [9], suggesting that apoptosis may play a role in
H5N1 pathogenesis in humans. In this study we demonstrate the
caspase-3-mediated cleavage of HDAC6 in IAV-infected cells and
discuss its signiﬁcance.2. Materials and methods
2.1. Cells, virus, and plasmids
Madin-Darby canine kidney (MDCK) epithelial cells were grown
in minimum essential medium (MEM) supplemented with 10%lsevier B.V. All rights reserved.
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(NHBE) cells (gift from Greg Conner, University of Miami) were
grown in BEGM media (Lonza). Inﬂuenza A virus (H1N1) New
Caledonia strain was propagated in embryonated chicken eggs.
Plasmid pcDNA3 (Invitrogen) expressing human HDAC6 with a
C-terminal FLAG tag was provided by Dr. Tso-Pang Yao (Duke
University). HDAC6 was cloned at NotI and XbaI sites of pcDNA3.
Point mutations in HDAC6 were introduced by QuickChange Site-
Directed Mutagenesis Kit (Stratagene) and conﬁrmed by DNA
sequencing.
2.2. Antibodies and reagents
Mouse anti-nucleoprotein (NP) antibody was purchased from
Chemicon. Rabbit anti-HDAC6 (amino acid 916-1215) and anti-ac-
tin antibodies were purchased from Santa Cruz and Abcam, respec-
tively. Rabbit anti-caspase-3 (cleaved) and anti-FLAG antibodies
were obtained from Cell Signaling. Horseradish peroxidase (HRP)-
conjugated donkey anti-mouse and anti-rabbit antibodies were
obtained from Afﬁnity Bioreagents and Pierce, respectively. Cas-
pase-3 inhibitor Z-DEVD-FMK was purchased from Calbiochem.
2.3. Infection and transfection
For infection, conﬂuent monolayers of cells were washed with
phosphate-buffered saline (PBS) supplemented with calcium and
magnesium. Virus inoculum, diluted in the PBS and supplemented
with 3 lg/ml trypsin was added to the cell monolayers. After 1 h
incubation at 37 C, inoculum was removed and cells were washed
once with PBS. Fresh medium was added and cells were incubated
at 37 C. Cells were transfected with the plasmids by Lipofectamine
2000 (Invitrogen) using manufacturer’s procedure. Brieﬂy, plasmid
DNA and Lipofectamine 2000 were separately diluted in the Opti-
MEM I medium (Invitrogen), mixed together and incubated at
room temperature for 20 min. The mixture was added to the cells
and incubated for 24 h at 37 C.
2.4. Western blotting
Cells were harvested, washed once with PBS, and lysed in lysis
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% TritonX-100, 0.5%
SDS, 0.5% sodium deoxycholate, and protease-inhibitor cocktail
[Roche]). The whole cell lysate was resolved on 10% Bis–Tris or 7%
Tris–acetate gels (Invitrogen). Proteinswere transferred to nitrocel-
lulose membrane and blocked with 5% nonfat milk in PBS. The
membrane was probed with primary antibody followed by second-
ary antibody at room temperature for 1 h. The antibody dilutions
were prepared in blocking solution. The membrane was washed
at least three times with PBS-T (0.05% Tween 20) after incubation
with each antibody and developed with the Dura chemilumines-
cent kit (Pierce). The membrane was stripped with Restore buffer
(Pierce) before re-probing with another antibody. Films were
scanned and images were compiled in Adobe Photoshop CS3.Fig. 1. HDAC6 polypeptide is degraded in IAV-infected epithelial cells. (a) MDCK
cells were transfected with parent plasmid pcDNA3 or HDAC6 plasmid. Cells were
then infected with IAV at multiplicity of infection (MOI) of 0.5. At 24 h post-
infection cells were harvested and lysed in lysis buffer. Total cell lysates were
resolved on SDS–PAGE, and HDAC6, NP, and actin were detected by Western
blotting. HDAC6 was detected with anti-HDAC6 antibody and a FLAG antibody.
Samples were re-run for detection with FLAG antibody, and combined here for
presentation. (b) Endogenous HDAC6 was detected in primary NHBE cells as above.
UNI, uninfected; INF, infected.3. Results
3.1. HDAC6 polypeptide is truncated in infected epithelial cells
We were interested in investigating the regulation of HDAC6 in
IAV-infected cells. However, we could not detect the endogenous
HDAC6 in MDCK cells with the available HDAC6 antibody. MDCK
cells are the best known system for IAV studies. Alternatively,
HDAC6 was expressed from a plasmid in MDCK cells, which were
then infected with IAV. Most of the HDAC6-expressing cells were
infected with IAV (Supplementary Fig. 1). Lysates from such cellswere analyzed byWestern blotting. A weak ormissing HDAC6 band
was observed in infected cell lysate as compared to the uninfected
cell lysate (Fig. 1a). This indicated the degradation or proteolytic
cleavage of HDAC6 in infected cells. However, the polyclonal anti-
body used to detect the HDAC6 also recognized non-speciﬁc pro-
teins besides HDAC6. To conﬁrm this observation, a FLAG
antibody was used to detect HDAC6 (plasmid-expressed HDAC6
has a C-terminal FLAG tag). Consistent with the above observation,
the FLAG antibody also detected a faint HDAC6 band in infected cell
lysate (Fig. 1a), further suggesting its degradation in IAV-infected
cells. Because HDAC6 detected here was expressed from a plasmid,
we next wanted to ﬁnd out whether endogenous HDAC6 was
undergoing the degradation too. Primary NHBE cells were used to
analyze this. As shown in Fig. 1b, endogenous HDAC6 is also trun-
cated in infected cells. To further conﬁrm this ﬁnding, a time course
study was performed where HDAC6-expressing cells were har-
vested after 6, 12, and 24 h of infection. Fig. 2a shows that the top
band representing HDAC6 disappeared as the infection progressed.
Incidentally, disappearance of the HDAC6 band coincided with the
cleavage of viral NP (Fig. 2a), which is known to undergo caspase-
3-mediated cleavage in infected cells [10]. We conﬁrmed the induc-
tion and activation of caspase-3 in IAV-infected MDCK cells by
detecting the full-length (procaspase) and cleaved (activated) forms
of the protein (Fig. 2b). To assess whether caspase-3was involved in
the degradation of HDAC6, infected cells were treated with the cas-
pase-3 inhibitor Z-DEVD-FMK. Indeed, full length of HDAC6 poly-
peptide was restored upon caspase-3 inhibition (Fig. 2c). At the
same time, cleavage of NP also was inhibited as indicated by its
slower mobility in the inhibitor-treated lysate (Fig. 2c, arrows),
showing the speciﬁcity of inhibitor. These data show that HDAC6
is undergoing caspase-3-dependent cleavage in IAV-infected cells.
3.2. HDAC6 C-terminus contains the caspase-3 cleavage site
Though HDAC6 degradation was inhibited upon caspase-3 inhi-
bition, the cleavage may not be directly mediated by caspase-3
Fig. 2. (a) Detection of HDAC6 polypeptide at different times after infection. MDCK cells were transfected and infected as in Fig. 1a. Cells were lysed after 6, 12, and 24 h of
infection, and HDAC6 and NP were detected by Western blotting in total cell lysates. Asterisks indicate the disappearing HDAC6 band and cleavage of NP. (b) Induction and
activation of caspase-3 in IAV-infected MDCK cells. Full-length and cleaved caspase-3, and actin were detected by Western blotting in total cell lysates. (c) Full length of
HDAC6 polypeptide is restored in the presence of caspase-3 inhibitor. Transfected MDCK cells were infected with IAV in the absence or presence of caspase-3 inhibitor Z-
DEVD-FMK (40 lM). HDAC6, NP, and actin were detected byWestern blotting in total cell lysates. Note: truncation of both HDAC6 and NP (arrows) is inhibited in the presence
of caspase-3 inhibitor.
Fig. 3. The C-terminus of HDAC6 contains the caspase-3 cleavage site. (a) Diagram showing the putative caspase-3 cleavage motifs and point mutations (shown in bold)
introduced in HDAC6. (b) MDCK cells transfected with wild-type or mutated HDAC6 plasmids were infected with IAV. HDAC6, NP, and actin were detected by Western
blotting in total cell lysates. HDAC6 was detected with anti-HDAC6 antibody and a FLAG antibody. Samples were re-run for detection with FLAG antibody and combined here
for presentation. The vertical line indicates the joining of the lanes from two similar blots.
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pase-dependent manner [11]. To assess whether HDAC6 is a true
caspase-3 substrate, we searched the HDAC6 sequence for the
presence of putative cleavage motifs. Caspases generally recognize
a DXXD motif on their substrates and speciﬁcally cleave after sec-
ond aspartic acid residue [12,13]. After examining the HDAC6 poly-
peptide we identiﬁed two potential caspase motifs, DTYD-S and
DMAD-S on the N- and C-termini, respectively (Fig. 3a). To test
whether these motifs contain the cleavage site(s), second aspartic
acid residues were mutated to glutamic acid. Three HDAC6 vari-
ants containing mutations at D172E, D1088E, and D172/1088E
positions were created (Fig. 3a), and then expressed in MDCK cells
before infecting with IAV. Analysis of infected cell lysates revealed
that the DMAD-S motif at C-terminus contained the actual cleav-
age site (Fig. 3b). Both D1088E and D172/1088E mutants retained
their full lengths in infected cells as detected by both HDAC6 and
FLAG antibodies, whereas wild-type HDAC6 and D172E mutant
were truncated as detected by only HDAC6 antibody (Fig. 3b). Fail-
ure of the FLAG antibody to detect wild-type HDAC6 and D172E
mutant in infected cell lysates further conﬁrmed that HDAC6 wastruncated at C-terminus. Detection of the cleaved NP in respective
lysates shows that caspase-3 was active. This data demonstrates
that HDAC6 serves as a caspase-3 substrate in IAV-infected cells.
4. Discussion
We have shown here that HDAC6 undergoes caspase-mediated
cleavage in IAV-infected cells. The experiments involving the
activation and inhibition of caspase-3 in infected cells clearly impli-
cate the caspase-3 in HDAC6 cleavage. Further, like some other cas-
pase-3 substrates [13], DMAD-S cleavagemotif identiﬁed in HDAC6
containsMet and Ser at3 and +1 positions, respectively. However,
we cannot rule out the involvement of other caspases in HDAC6
cleavage because Z-DEVD-FMK also inhibits caspase-6, -7 and -8.
HDAC3 and 4 also have been shown to undergo caspase-dependent
cleavage albeit in different systems [14,15]. This report, for the ﬁrst
time, shows the regulation of an HDAC during virus infection. Inter-
estingly, HDAC6 was not cleaved by the recombinant caspase-3
in vitro [15], suggesting that only in vivo-induced caspase-3 is able
to cleave it. Cleavage of HDAC3 and 4 promotes their cytoplasmic
Fig. 4. Diagram showing the removal of the BUZ domain from HDAC6 upon
caspase-3 cleavage.
2520 M. Husain, K.S. Harrod / FEBS Letters 583 (2009) 2517–2520localization and apoptosis [14,15]. However, HDAC6 is already
localized to the cytoplasm, and the serine-glutamic acid repeat
(SE14) domain at C-terminus (residues 888–1024) acts as a cyto-
plasmic retention signal [1]. Downstream of the SE14 domain
HDAC6 contains ubiquitin-binding bound to ubiquitin zinc ﬁnger
(BUZ) domain (Fig. 4). The caspase-3 cleavage site identiﬁed in this
study is present between the SE14 and BUZ domains, and cleavage
removes most of the BUZ domain from HDAC6 (Fig. 4). As of yet, we
do not know the signiﬁcance of removal of BUZ domain in IAV-in-
fected cells. However, besides being essential for HDAC6 to process
the misfolded proteins, the BUZ domain also is required for regula-
tion of hsp90 [4]. Hsp90 has recently been shown to be involved in
IAV replication [16]. It is also likely that consequent exposure of
SE14 region after BUZ domain removal stabilizes the cytoplasmic
retention of HDAC6. Consequently, like HDAC3 and HDAC4, stable
cytoplasmic retention of HDAC6 promotes apoptosis in IAV-in-
fected cells, which can be beneﬁcial for IAV replication. It has been
reported that inhibition of apoptosis in infected cells signiﬁcantly
impairs the IAV propagation [17].
HDAC6 may play a critical role during IAV replication as all
known HDAC6 substrates, a-tubulin, hsp90, and cortactin, are
potentially involved in IAV replication [16,18]. IAV replicates in
the nucleus and assembles on the plasma membrane of infected
cells. IAV particles consist of three major components: the viral
envelope, matrix protein (M1), and viral ribonucleoprotein (vRNP)
core [19]. During assembly, constituents of viral envelope are di-
rectly transported to the plasma membrane via secretory pathway.
However, M1, and vRNP constituents NP and RNA polymerase sub-
units are ﬁrst imported into the nucleus for vRNP assembly. M1
and vRNP are then exported out of the nucleus and transported
to the plasma membrane via an unknown pathway [19]. Hsp90,
possibly as a molecular chaperone, regulates the nuclear transport
of RNA polymerase subunits [16]. We anticipate that microtubules
play a signiﬁcant role in vRNP trafﬁcking because vRNPs have been
colocalized with microtubules [18] and a-tubulin is hyperacetylat-
ed in IAV-infected cells (Husain, M., unpublished). Another HDAC6
substrate, cortactin, may be involved in the budding and release of
IAV particles by way of its interaction with actin [20]. Previously,
actin has been shown to associate with IAV M1 and NP in infected
cells [21]. Moreover, HDAC6 also regulates actin remodeling under
the plasma membrane [4], the site for IAV assembly and budding.
Studies are underway to determine the signiﬁcance of HDAC6 reg-
ulation in IAV-infected cells.
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